Trials / Sponsors / Nymox Corporation
Nymox Corporation
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)(NX02-002 Benign Prostatic Hyperplasia, BPH, Lower Urinary Tract Symptoms (LUTS) | Phase 3 | 2013-04-01 |
| Completed | Two-Dose Level Evaluation of NX-1207 for the Treatment of Low Risk, Localized (T1c) Prostate Cancer Prostate Cancer | Phase 2 | 2012-02-21 |
| Completed | Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) Benign Prostatic Hyperplasia | Phase 3 | 2011-09-01 |
| Completed | Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018 Benign Prostatic Hyperplasia (BPH) | Phase 3 | 2009-05-01 |
| Completed | Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) Benign Prostatic Hyperplasia | Phase 3 | 2009-04-01 |
| Completed | Phase 2 Study of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) (Enlarged Prostate) Benign Prostatic Hyperplasia (BPH), Enlarged Prostate | Phase 2 | 2007-05-01 |